Ofer MANDELBOIM,Angel PORGADOR,Yaakov NAPARSTEK,Chamutal GUR
申请号：
US13862927
公开号：
US20130280209A1
申请日:
2013.04.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes.
